FNDC5 and metabolic dysfunction-associated steatotic liver disease: Among them, Fndc5/Irisin, which is well known to promote the browning of white adipose tissue, enhances muscle hypertrophy and alleviates obesity and hepatic steatosis, was significantly decreased in both NAFLD and NASH groups.